Trial Profile
Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD)
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 15 Dec 2022
Price :
$35
*
At a glance
- Drugs Guanfacine (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- 15 Dec 2022 Status changed from completed to recruiting.
- 14 Dec 2022 Status changed from recruiting to completed.
- 04 May 2017 New trial record